研究简报

巴戟天内生真菌Trichoderma spirale A725中两个新的聚酮类化合物

  • 陈书帅 ,
  • 刘洪新 ,
  • 刘昭明 ,
  • 李赛妮 ,
  • 陈玉婵 ,
  • 李浩华 ,
  • 李冬利 ,
  • 章卫民
展开
  • a 五邑大学生物科技与大健康学院 广东江门 529020;
    b 广东省微生物研究所 广东省科学院 华南应用微生物国家重点实验室 广东省菌种保藏与应用重点实验室 广东省微生物应用新技术公共实验室 广州 510075

收稿日期: 2019-07-26

  修回日期: 2019-09-10

  网络出版日期: 2019-09-25

基金资助

国家自然科学基金(No.31600271)、广东省科技计划(No.2107A020211023)和广州市珠江科技新星(No.201806010080)资助项目.

Two New Polyketide Compounds from the Endophytic Fungus Trichoderma spirale A725 of Morinda officinalis

  • Chen Shushuai ,
  • Liu Hongxin ,
  • Liu Zhaoming ,
  • Li Saini ,
  • Chen Yuchan ,
  • Li Haohua ,
  • Li Dongli ,
  • Zhang Weimin
Expand
  • a School of Biotechnology and Health Sciences, Wuyi University, Jiangmen, Guangdong 529020;
    b State Key Laboratory of Applied Microbiology Southern China, Guangdong Provincial Key Laboratory of Microbial Culture Collection and Application, Guangdong Open Laboratory of Applied Microbiology, Guangdong Institute of Microbiology, Guangdong Academy of Sciences, Guangzhou 510070

Received date: 2019-07-26

  Revised date: 2019-09-10

  Online published: 2019-09-25

Supported by

Project supported by the National Natural Science Foundation of China (No. 31600271), the Guangdong Provincial Project for Science and Technology (No. 2107A020211023), and the Pearl River Science and Technology New Star Fund of Guangzhou City (No. 201806010080).

摘要

综合运用硅胶柱色谱、反相硅胶柱色谱、Sephadex LH-20凝胶柱色谱以及制备型高效液相色谱技术对药用植物巴戟天内生真菌Trichoderma spirale A725的次生代谢产物进行分离纯化,得到6个聚酮类化合物,采用多种现代波谱技术确定其结构,分别为:6-羟基-4-异丙基-1,8-二甲基螺环[4.5]癸-1,8-二烯-7-酮(1),2-羟基-2,5-二甲基-7-氧代-5,7-二氢-2H-呋喃[3,4-b]吡喃-4-羧酸(2),3-乙基-4-羟基-6-甲基-二氢-吡喃-2-酮(3),苯乙内酯A(4),3-羟基-5-(4-羟基苄基)二氢呋喃-2(3H)-酮(5),4-乙酰-3-羟基-6-甲基吡喃-2-酮(6).其中化合物12为新化合物,化合物3为新天然产物.此外,利用四株肿瘤细胞株(HepG-2、MCF-7、SF-268及A549)对化合物1~6细胞毒活性进行评估,结果表明化合物1~6对上述肿瘤细胞均无明显的细胞毒活性.

本文引用格式

陈书帅 , 刘洪新 , 刘昭明 , 李赛妮 , 陈玉婵 , 李浩华 , 李冬利 , 章卫民 . 巴戟天内生真菌Trichoderma spirale A725中两个新的聚酮类化合物[J]. 有机化学, 2020 , 40(1) : 209 -214 . DOI: 10.6023/cjoc201907041

Abstract

Six polyketides were isolated from the fermentation broth of an endophytic fungus Trichoderma spirale A725 of the medicinal plant Morinda officinalis by silica gel, reversed phase silica column chromatography, sephadex LH-20 and high performance preparative liquid chromatography. Their structures were elucidated to be 6-hydroxy-4-isopropyl-1,8-dimethyl-spiro[4.5]deca-1,8-dien-7-one (1), 2-hydroxy-2,5-dimethyl-7-oxo-5,7-dihydro-2H-furo[3,4-b]pyran-4-carboxylicacid (2), 3-ethyl-4-hydroxy-6-methyl-2H-pyran-2-one (3), harzialactone A (4), 3-hydroxy-5-(4-hydroxybenzyl)dihydrofuran-2(3H)-one (5), and 4-acetyl-3-hydroxy-6-methyl-pyran-2-one (6) on the basis of extensive spectral analysis. Among them, compounds 1 and 2 were new compounds, and compound 3 was a new natural product. Moreover, the cytotoxicities of compounds 1~6 were evaluated against four cancer cell lines (Hep G-2, MCF-7, SF-268 and A549). However, none of them exhibited cytotoxic activity against the tested tumor cells.

参考文献

[1] Pharmacopoeia Committee of China Pharmacopoeia of People's Republic of China, China Medical Science and Technology Press, Beijing, 2015, pp. 81~82(in Chinese). (中国药典编辑委员, 中国药典, 中国医药科技出版社, 北京, 2015, pp. 81~82.)
[2] Tan, R. X.; Zou, W. X. Nat. Prod. Res. 2001, 18, 448.
[3] Shi, Q. Y.; Chen, X. M.; Guo, S. X. J. Chin. Pharm. Sci. 2007, 42, 804(in Chinese). (施琦渊, 陈晓梅, 郭顺星, 中国药学杂志, 2007, 42, 804.)
[4] Isaka, M.; Prathumpai, W.; Wongsa, P.; Tanticharoen, M. Org. Lett. 2006, 8, 2815.
[5] Chen, L.; Niu, S. B.; Li, L.; Ding, G.; Yu, M.; Zhang, G. S.; Wang, M. H.; Li, L. Y.; Zhang, T.; Jia, H. M.; Zhang, H. W.; Shang, H.; Liu, X. Z.; Zou, Z. M. J. Nat. Prod. 2017, 80, 1944.
[6] Song, F.; Dai, H.; Tong, Y.; Ren, B.; Chen, C.; Sun, N.; Liu, X.; Bian, J.; Liu, M.; Gao, H.; Liu, H.; Chen, X.; Zhang, L. J. Nat. Prod. 2010, 73, 806.
[7] Sun, Y.; Tian, L.; Huang, J.; Ma, H. Y.; Zheng, Z.; Lv, A. L.; Yasukawa, K.; Pei, Y. H. Org. Lett. 2008, 10, 393.
[8] Zhao, J. L.; Zhang, M.; Liu, J. M.; Tan, Z.; Chen, R. D.; Xie, K. B.; Dai, J. G. J. Asian Nat. Prod. Res. 2017, 19, 1028.
[9] Miao, F. P.; Liang, X. R.; Yin, X. L.; Wang, G.; Ji, N. Y. Org. Lett. 2012, 14, 3815.
[10] Zhang, M.; Li, N.; Chen, R. D.; Zou, J. H.; Wang, C. M.; Dai, J. G. J. Chin. Pharm. Sci. 2014, 23, 421(in Chinese). (张敏, 李宁, 陈日道, 邹建华, 王春梅, 戴均贵, 中国药学杂志, 2014, 23, 421.)
[11] Sun, Y.; Lv, A. L.; Tian, L.; Wei, L.; Pei, Y. H. J. Shenyang Pharm. Univ. 2007, 24, 546(in Chinese). (孙弈, 吕阿丽, 田黎, 魏岚, 裴月湖, 沈阳药科大学学报, 2007, 24, 546.)
[12] Sun, S.; Tian, L.; Wu, Z. H.; Chen, G.; Wu, H. H.; Wang, Y. N.; Pei, Y. H. J. Asian Nat. Prod. Res. 2009, 11, 898.
[13] Ly, Q.; Tan, R.; Zhang, Y. L.; Cheng, Y. X. Acta Bot. Yunnan 2007, 29, 375(in Chinese). (吕青, 谭睿, 张永利, 程永现, 云南植物研究, 2007, 29, 375.)
[14] Kappe, T.; Aigner, R.; Roschger, P.; Schnell, B.; Stadlbauer, W. Tetrahedron 1995, 51, 12923.
[15] Skehan, P.; Storeng, R.; Scudiero, D.; Monks, A.; McMahon, J.; Vistica, D.; Warren, J. T.; Bokesch, H.; Kenney, S.; Boyd, M. R. J. Natl. Cancer Inst. 1990, 82, 1107.
文章导航

/